BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2014 6:27:00 PM | Browse: 1048 | Download: 1010
 |
Received |
|
2013-11-12 15:27 |
 |
Peer-Review Started |
|
2013-11-13 14:17 |
 |
To Make the First Decision |
|
2013-12-25 18:06 |
 |
Return for Revision |
|
2013-12-31 14:35 |
 |
Revised |
|
2014-01-03 04:58 |
 |
Second Decision |
|
2014-03-17 14:39 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-03-17 14:51 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-04-18 20:18 |
 |
Publish the Manuscript Online |
|
2014-04-28 14:14 |
Category |
Oncology |
Manuscript Type |
Topic Highlights |
Article Title |
Allogeneic hematopoietic cell transplant for acute myeloid leukemia: Current state in 2013 and future directions
|
Manuscript Source |
Invited Manuscript |
All Author List |
Abraham S Kanate, Marcelo C Pasquini, Parameswaran N Hari and Mehdi Hamadani |
Funding Agency and Grant Number |
|
Corresponding Author |
Mehdi Hamadani, MD, Associate Professor of Medicine, Division of Hematology and Oncology, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, WI 53226, United States. mhamadani@mcw.edu |
Key Words |
Acute myeloid leukemia; Allogeneic hematopoietic cell transplantation; Reduced intensity conditioning; Myeloablative conditioning; Haploidentical; Umbilical cord blood |
Core Tip |
Acute myeloid leukemia (AML) represents a heterogeneous group of high-grade myeloid neoplasms of the elderly with variable outcomes. We discuss the role of allo-hematopoietic cell transplantation (HCT) in AML patients stratified by cytogenetic- and molecular-risk in first complete remission, as well as allo-HCT as an option in relapsed/refractory AML. |
Publish Date |
2014-04-28 14:14 |
Citation |
Kanate AS, Pasquini MC, Hari PN, Hamadani M. Allogeneic hematopoietic cell transplant for acute myeloid leukemia: Current state in 2013 and future directions. World J Stem Cells 2014; 6(2): 69-81 |
URL |
http://www.wjgnet.com/1948-0210/full/v6/i2/69.htm |
DOI |
http://dx.doi.org/10.4252/wjsc.v6.i2.69 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345